Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2-Positive Breast Cancer: A Secondary Analysis of the DAPHNe Trial.
Journal: JAMA oncology
Published: June 25, 2026
The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 10, 2026
Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancer.
Journal: NPJ precision oncology
Published: October 07, 2025
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 23, 2025
Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction.
Journal: Cell
Published: February 23, 2025
Ultra-sensitive, tumor-informed ctDNA profiling in pembrolizumab-treated esophagogastric cancer patients predicts clinical responses.
Journal: Research square
Published: January 07, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 19, 2024
Whole genome sequencing-powered ctDNA sequencing for breast cancer detection.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 15, 2024
Prevalence of synonymous mutations in m6A modification sites in human cancers.
Journal: Genes & diseases
Published: May 11, 2024
Last Updated: 09/26/2026